Literature DB >> 1599358

Undiagnosed migraine headaches. A comparison of symptom-based and reported physician diagnosis.

R B Lipton1, W F Stewart, D D Celentano, M L Reed.   

Abstract

BACKGROUND: Although migraine headaches are a common cause of temporary disability, many people with migraine have not been diagnosed. In a sample of the US population, we sought to determine the proportion of migraineurs diagnosed by a physician and to identify the headache characteristics and sociodemographic profiles associated with undiagnosed migraine.
METHODS: A mail questionnaire survey was sent to 15,000 US households, selected from a panel to be representative of the US population. Of a total study base population of 23,611, excluding 3043 subjects less than 12 years of age and respondents with unreported gender, we analyzed data for 20,468 subjects aged 12 to 80 years. Migraine diagnoses were assigned on the basis of reported symptoms by means of operational diagnostic criteria. Physician diagnosis of migraine was ascertained on the basis of self-report.
RESULTS: Forty-one percent of female and 29% of male migraineurs reported having been diagnosed by a physician. Diagnosis was more likely in females, in people with high income levels, and in individuals who reported migraine associated with aura, vomiting, or disability. Of the undiagnosed subjects, 80% experienced at least some headache-related disability.
CONCLUSIONS: Results of this survey indicate that the majority of people with migraine in the United States do not report having been diagnosed by a physician. Given the high proportion of undiagnosed subjects with headache-related disability, efforts to improve the diagnosis and treatment of migraine are recommended.

Entities:  

Mesh:

Year:  1992        PMID: 1599358     DOI: 10.1001/archinte.152.6.1273

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  31 in total

Review 1.  Sumatriptan. A pharmacoeconomic review of its use in migraine.

Authors:  A J Coukell; H M Lamb
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

Review 2.  The burden of migraine. A review of cost to society.

Authors:  R B Lipton; W F Stewart; M Von Korff
Journal:  Pharmacoeconomics       Date:  1994-09       Impact factor: 4.981

Review 3.  Oral serotonin receptor agonists: a review of their cost effectiveness in migraine.

Authors:  Jennifer H Lofland; David B Nash
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

4.  The medical care utilization and costs associated with migraine headache.

Authors:  Jennifer Elston Lafata; Christina Moon; Carol Leotta; Ken Kolodner; Laila Poisson; Richard B Lipton
Journal:  J Gen Intern Med       Date:  2004-10       Impact factor: 5.128

5.  Population-based study of migraine in Spanish adults: relation to socio-demographic factors, lifestyle and co-morbidity with other conditions.

Authors:  César Fernández-de-Las-Peñas; Valentín Hernández-Barrera; Pilar Carrasco-Garrido; Cristina Alonso-Blanco; Domingo Palacios-Ceña; Silvia Jiménez-Sánchez; Rodrigo Jiménez-García
Journal:  J Headache Pain       Date:  2009-12-10       Impact factor: 7.277

6.  Migraine in postmenopausal women and the risk of invasive breast cancer.

Authors:  Robert W Mathes; Kathleen E Malone; Janet R Daling; Scott Davis; Sylvia M Lucas; Peggy L Porter; Christopher I Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

7.  Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.

Authors:  André Pradalier; Jean-Paul Auray; Abdelkader El Hasnaoui; Kazem Alzahouri; Jean-François Dartigues; Gérard Duru; Patrick Henry; Michel Lantéri-Minet; Christian Lucas; Guy Chazot; Anne-François Gaudin
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

8.  Is the comorbidity of epilepsy and migraine due to a shared genetic susceptibility?

Authors:  R Ottman; R B Lipton
Journal:  Neurology       Date:  1996-10       Impact factor: 9.910

9.  The burden of migraine in Spain: beyond direct costs.

Authors:  Xavier Badia; Sol Magaz; Laura Gutiérrez; Jordi Galván
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

10.  Diagnosing migraine in research and clinical settings: the validation of the Structured Migraine Interview (SMI).

Authors:  Zainab Samaan; E Anne Macgregor; Dowson Andrew; Peter McGuffin; Anne Farmer
Journal:  BMC Neurol       Date:  2010-01-14       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.